Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Boehringer Ingelheim Invests £150 Million to Expand Global AI Footprint in the UK
Boehringer Ingelheim is expanding its global Computational Innovation network with a new artificial intelligence AI and machine learning ML centre in Kings Cross, London
Evonik Invests €80 Million to Expand Biotechnology Capabilities in Slovakia
Evonik has invested 80 million to expand its biotechnology capabilities in Slovakia, strengthening its production capacity and innovation capabilities for sustainable biosolutions and advanced bioprocessing applications
AbbVie Invests $1.4 Billion to Expand North Carolina Manufacturing Campus
AbbVie has announced a $14 billion investment to establish a 185acre pharmaceutical manufacturing campus in Durham to support the production of immunology, neuroscience, and oncology medicines in the United States
LGM Pharma Expands U.S. Manufacturing with $15 Million Investment across Texas and Colorado Sites
LGM Pharma has announced a further expansion of its contract development and manufacturing operations in the United States, bringing its total investment across sites in Texas and Colorado to $15 million
Wilmington PharmaTech Invests $50 Million to Double U.S. API Manufacturing Capacity
Wilmington PharmaTech, a USbased contract research, development, and manufacturing organisation CRDMO, has announced a $50 million expansion of its Delaware campus The project aims
ESTEVE CDMO Invests $15.5 Million to Expand Chicago Small Molecule API Facility
ESTEVE CDMO has launched a $155 million expansion of its North American facility in Morton Grove, Illinois
Novo Nordisk Invests €432 Million to Expand Athlone Manufacturing Facility
Novo Nordisk has announced an investment of 432 million to expand its tabletting facility in Ireland
Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility
Axplora, a contract development and manufacturing organisation CDMO specialising in complex small molecules and antibodydrug conjugates ADCs, has announced a major investment to expand its lyophilization freezedrying
Novartis Strengthens US Operations with $23B Radioligand Therapy Expansion
Novartis has announced plans to build a 46,000squarefoot radioligand therapy RLT manufacturing site in Denton This will be the companys fifth RLT site in the United States and its first manufacturing facility in Texas
FUJIFILM Invests £400M to Expand Biomanufacturing and Process Development Capacity
FUJIFILM Biotechnologies, a global contract development and manufacturing organisation CDMO for biologics, vaccines, and advanced therapies, has expanded its site in Teesside, UK, with a total investment
